Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-006278
Filing Date
2017-02-06
Accepted
2017-02-06 19:01:54
Documents
1
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v458421_5.html 5  
1 OWNERSHIP DOCUMENT v458421_5.xml 5 8689
  Complete submission text file 0001144204-17-006278.txt   10306
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAPRICOR THERAPEUTICS, INC. 8840 WILSHIRE BLVD., 2ND FLOOR BEVERLY HILLS CA 90211
Business Address
Marban Linda (Reporting) CIK: 0001593084 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-34058 | Film No.: 17576796